Experience the Power of the Full LEAF.

Full-spectrum CBD contains all the compounds in the cannabis plant. These include: * Cannabinoids: CBD and delta-9 tetrahydrocannabinol (THC) are two cannabinoids found in cannabis. * Terpenes: These compounds provide cannabis with its scent and flavor. Terpenes can also enhance the effects of cannabinoids, such as promoting relaxation, stress relief, and boosting energy and focus. * Flavonoids: There are about 20 flavonoids in the cannabis plant, and they are also present in fruits, vegetables, and flowers. According to a 2019 study, flavonoids provide an anti-inflammatory effect.

CBD can benefit a variety of health conditions. While research is ongoing, some studies show a positive correlation between taking CBD and improved anxiety & depression symptoms, improved ALS symptoms and reduced levels of chronic pain, among other health conditions. While CBD isn't a substitution for prescribed medications it may offer some relief, and can be used to help manage a variety of health concerns. Including- Chronic pain, Inflammation, Insomnia, Poor appetite, Depression, Anxiety, Certain epilepsy conditions, and Substance misuse disorders. Visit the "What The Experts Say" section to explore more of the benefits of CBD. Source linked in 'menu' under the tab 'sources'.

Full-spectrum CBD contains all the natural compounds present in the hemp plant. CBD isolate is the pure form of CBD (also known as Pure CBD), it does not contain the other properties including THC, terpenes, and flavonoids.

CBD is often well-tolerated amongst adults. However, ones new to usage can experience side effects such as: dry mouth, diarrhea, reduced appetite, drowsiness and fatigue. We recommend those new to CBD start with a low dose, per product label instructions. Take note of how you feel and whether you experience your desired wellness goals. If you experience unwanted side effects, it may be beneficial to explore other treatment options.

Because the FDA currently does not regulate CBD, there are no specific recommended doses. Doses in most clinical trials have ranged from 100 to 800 milligrams a day. Please adhere to the products serving sizes. Before using any CBD product, you should speak to your doctor to come up with a safe dosage plan that works for you. This plan should also take into account your symptoms and any other medications or supplements that you may be taking.

Studies show that Full-Spectrum CBD is more effective for pain relief when compared to isolate CBD & Broad-Spectrum CBD. A lot of people prefer Full-Spectrum CBD, seeing the benefits more often then Isolate CBD & Broad-Spectrum CBD products because Full-Spectrum CBD products tend to have a stronger effect. We recommend those new to Full-Spectrum CBD start with a low dose, per product label instructions. Take note of how you feel and whether you experience your desired wellness goals. If you have health concerns consult your physician before beginning any cannabis product.

A 2017 study in the Brazilian Journal of Psychiatry tested the anxiety levels of 57 men in a simulated public speaking test. Some received a placebo while others received either 150 milligrams, 300 milligrams or 600 milligrams of CBD before their speeches. Those who received 300 milligrams of CBD experienced significantly reduced anxiety during the test compared to those who received the placebo. Interestingly, participants who received either 150 or 600 milligrams of CBD experienced more anxiety during the test than the 300 milligrams group. The trial enrolled 250 patients with chronic pain in the lower back, hip, or knee. Participants also had at least moderate depression, as measured by a standard clinical instrument. One group was assigned to 12 weeks of antidepressant therapy followed by a 12-week pain self-management intervention based on principles of CBT. In the "usual care" group, which served as a control, researchers informed participants that they had depression and should seek advice or treatment. Results were considered significant if participants reported at least a 50% reduction in depression severity and at least a 30% reduction in pain. At the 12-month mark, both depression and pain were significantly reduced in 32 of 123 intervention patients (roughly one in four), compared with 10 of 127 usual care participants (about one in 12). In 2018, the Food and Drug Administration (FDA) approved the use of CBD under the brand name Epidiolex to treat seizures resulting from Lennox-Gastaut syndrome and Dravet syndrome—two rare forms of epilepsy—in patients at least 2 years old. Three well-vetted studies provide the basis of support for the FDA’s decision. In these trials, 516 patients with Lennox-Gastaut syndrome or Dravet syndrome received either Epidiolex or a placebo. Epidiolex, when taken along with other prescribed medications, decreased the frequency of participants’ seizures compared to the placebo. In a small 2018 study in the Journal of Alternative and Complementary Medicine, 11 people with post-traumatic stress disorder (PTSD) received CBD along with routine psychiatric care for eight weeks in an outpatient psychiatric clinic. Ten of the 11 experienced a decrease in their PTSD symptoms. CBD was generally well tolerated, the researchers write. Margaret Rajnic, a doctor of nursing practice experienced in medical cannabis and CBD, emphasizes the importance of using therapy in tandem with any type of cannabis or CBD for PTSD. “There is an amount of therapy that is needed for PTSD,” she says. “But CBD will give you that little bit of decreased anxiety.” Four other human trials from 2012 to 2016 suggest CBD reduces PTSD symptoms, although some include THC, or tetrahydrocannabinol, the main mind-altering element in cannabis. When THC and CBD work together, they create what’s called an “entourage effect,” complementing each other’s benefits and potency. For example, taking the same dose of THC and CBD together tempers the “high” from THC, while just a little THC paired with more CBD enhances the effects of the CBD. In a 2019 study, patients received a combination of THC and CBD in varying doses depending on their needs and preferences. Those with mild, moderate or severe spasticity (muscle tightness and stiffness) due to ALS reported high levels of satisfaction with the treatment, and those with moderate to severe spasticity reported higher satisfaction rates than those with mild spasticity. In one 2020 study, researchers administered CBD topically to a group of patients with symptomatic peripheral neuropathy (a result of brain nerve and spinal cord nerve damage) while another group with the same condition received a placebo. Results showed a significant reduction in intense, sharp pains and cold, itchy sensations in those who used the topical CBD compared to those who used the placebo. No participants reported adverse side effects. A 2006 study found that Sativex—a CBD-based botanical drug approved in the United Kingdom in 2010—promoted statistically significant improvements in quality of sleep, pain during movement and pain at rest in patients with rheumatoid arthritis when compared to a placebo. It was the first controlled trial of Sativex as a treatment for rheumatoid arthritis, involving 58 patients. CBD was found to have a pain-relieving effect, as well as an ability to suppress disease activity. The case studies mentioned above have been sourced and linked- to view click 'menu' then click 'sources'.